Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shirabe

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone?H Uchiyama, K Shirabe, H Nakagawara, et al.
International Journal of Oral and Maxillofacial Surgery|January 8, 2021
Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resectionT Yamaguchi, T Makiguchi, H Nakamura, et al.
Transplantation Proceedings|May 20, 2014
Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosisN Harimoto, T Ikegami, H Nakagawara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2011
The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft caseT Motomura, A Taketomi, T Fukuhara, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatmentT Hatanaka, S Kakizaki, T Nagashima, et al.
Transplantation Proceedings|April 21, 2015
Thymoglobulin for steroid-resistant immune-mediated graft dysfunction during simeprevir-based antiviral treatment for post-transplantation hepatitis C: case reportK Takeishi, T Ikegami, T Yoshizumi, et al.
British Journal of Cancer|January 14, 2015
Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantationK Sugimachi, T Matsumura, H Hirata, et al.
Clinical and Experimental Immunology|June 19, 2013
Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis CK Sumida, S Shimoda, S Iwasaka, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Correlation between portal vein anatomy and bile duct variation in 407 living liver donorsK Takeishi, K Shirabe, Y Yoshida, et al.
Transplantation Proceedings|November 19, 2017
Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait SpeedN Harimoto, T Yoshizumi, T Izumi, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Revisiting the safety of living liver donors by reassessing 441 donor hepatectomies: is a larger hepatectomy complication-prone?H Uchiyama, K Shirabe, H Nakagawara, et al.
International Journal of Oral and Maxillofacial Surgery|January 8, 2021
Impact of muscle volume loss on acute oral mucositis in patients undergoing concurrent chemoradiotherapy after oral cancer resectionT Yamaguchi, T Makiguchi, H Nakamura, et al.
Transplantation Proceedings|May 20, 2014
Chronic immune-mediated reaction syndrome as the cause of late graft mortality in living-donor liver transplantation for primary biliary cirrhosisN Harimoto, T Ikegami, H Nakagawara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2011
The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft caseT Motomura, A Taketomi, T Fukuhara, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
A change in the timing for starting systemic therapies for hepatocellular carcinoma: the comparison of sorafenib and lenvatinib as the first-line treatmentT Hatanaka, S Kakizaki, T Nagashima, et al.
Transplantation Proceedings|April 21, 2015
Thymoglobulin for steroid-resistant immune-mediated graft dysfunction during simeprevir-based antiviral treatment for post-transplantation hepatitis C: case reportK Takeishi, T Ikegami, T Yoshizumi, et al.
British Journal of Cancer|January 14, 2015
Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantationK Sugimachi, T Matsumura, H Hirata, et al.
Clinical and Experimental Immunology|June 19, 2013
Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis CK Sumida, S Shimoda, S Iwasaka, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 19, 2014
Correlation between portal vein anatomy and bile duct variation in 407 living liver donorsK Takeishi, K Shirabe, Y Yoshida, et al.
Transplantation Proceedings|November 19, 2017
Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait SpeedN Harimoto, T Yoshizumi, T Izumi, et al.
Pageof 18